Effects of RNA Secondary Structure on Alternative Splicing of Pre-mRNA: is Folding Limited to a Region Behind the Transcribing RNA Polymerase?

Overview

Journal Cell

Publisher Cell Press

Specialty Cell Biology

Date 1988 Jul 29

PMID 2840206

Citations 129

Authors

L P Eperon

I R Graham

A D Griffiths

I C Eperon

Affiliations

Soon will be listed here.

Abstract

The use in vivo of an alternative 5' splice site sequestered within a short stem of potential RNA secondary structure is determined by the length of the loop. Above a threshold length of loop, the alternative site is used despite the potential structure. In contrast, the alternative site is used very little or not at all during splicing in vitro with all lengths of loop that we have tested. A model is proposed which suggests that pre-mRNA is free to fold only within a limited period after transcription.

Citing Articles

From benign to pathogenic variants and vice versa: pyrimidine transitions at position -3 of TAG and CAG 3' splice sites.

Vorechovsky I J Hum Genet. 2024; 70(3):125-133.

PMID: 39639151 PMC: 11802449. DOI: 10.1038/s10038-024-01308-8.

Alternative splicing is coupled to gene expression in a subset of variably expressed genes.

Karlebach G, Steinhaus R, Danis D, Devoucoux M, Anczukow O, Sheynkman G NPJ Genom Med. 2024; 9(1):54.

PMID: 39496626 PMC: 11535429. DOI: 10.1038/s41525-024-00432-w.

Isoginkgetin and Madrasin are poor splicing inhibitors.

Tellier M, Ansa G, Murphy S PLoS One. 2024; 19(10):e0310519.

PMID: 39432454 PMC: 11493277. DOI: 10.1371/journal.pone.0310519.

Aberrant pre-mRNA processing in cancer.

Biswas J, Boussi L, Stein E, Abdel-Wahab O J Exp Med. 2024; 221(11).

PMID: 39316554 PMC: 11448470. DOI: 10.1084/jem.20230891.

RNA structure in alternative splicing regulation: from mechanism to therapy.

Bao N, Wang Z, Fu J, Dong H, Jin Y Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):3-21.

PMID: 39034824 PMC: 11802352. DOI: 10.3724/abbs.2024119.